AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
Go back to AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio| AbbVie (NYSE: ABBV) | Delayed: 256.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.42 | 52 Week High | $68.12 | |||
| Open | $256.42 | 52 Week Low | $50.71 | |||
| Day High | $256.42 | P/E | 55.62 | |||
| Day Low | $256.42 | EPS | $4.61 | |||
| Volume | 309 | |||||
| Apogee Robotics (NASDAQ: APGE) | Delayed: 135.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.08 | 52 Week High | $0.02 | |||
| Open | $135.08 | 52 Week Low | $0.02 | |||
| Day High | $135.08 | P/E | N/A | |||
| Day Low | $135.08 | EPS | $0.00 | |||
| Volume | 1,631 | |||||
